The pharmaceutical industry constantly seeks innovative tools to enhance drug discovery, development, and diagnostic capabilities. Near-Infrared (NIR) dyes, known for their ability to penetrate tissues deeper and with less background interference than visible light dyes, have become indispensable in this pursuit. New Indocyanine Green (CAS: 172616-80-7), often referred to by its designation IR-820, is a prime example of such a critical reagent.

As a powerful infrared blood pool contrast agent and a robust near-infrared fluorescent dye, IR-820 is instrumental in various stages of pharmaceutical research and development (R&D). Its primary application in preclinical settings involves in-vivo imaging, where it enables researchers to visualize and quantify biological processes. This includes the detection and analysis of diseased tissues in live animal models, providing invaluable data for understanding disease mechanisms and evaluating the efficacy of potential drug candidates.

For pharmaceutical companies and contract research organizations (CROs) looking to buy New Indocyanine Green IR-820, the emphasis is always on quality and reliability. The compound's high purity, typically stated at 97% or higher, is a non-negotiable requirement. This ensures that imaging results are accurate, reproducible, and can be confidently used to support regulatory submissions. The physical form of the dye, a green powder with a high melting point, also contributes to its handling and formulation stability.

When considering the procurement of IR-820, understanding the price of New Indocyanine Green is important, but should not overshadow quality and supply chain reliability. Manufacturers specializing in fine chemicals and pharmaceutical intermediates, particularly those operating from China, are significant global suppliers. Engaging directly with these entities or their established distributors to obtain quotes for bulk purchases can lead to cost efficiencies. This is vital for R&D budgets, which often require large quantities of reagents for extensive testing.

The role of ICG extends to tracking drug distribution within the body and assessing the impact of therapeutic interventions on tissue perfusion. Its ability to remain within the vascular system due to protein binding makes it an excellent indicator of blood pool dynamics. This characteristic is crucial for pharmacokinetics and pharmacodynamics studies, helping researchers understand how a drug is absorbed, distributed, metabolized, and excreted.

In conclusion, New Indocyanine Green IR-820 is a cornerstone reagent for modern pharmaceutical R&D. Its effectiveness as an infrared contrast agent and NIR dye, coupled with the availability from reliable suppliers offering competitive pricing, makes it an accessible and essential tool. For organizations engaged in drug discovery and development, sourcing this high-quality chemical from a trusted manufacturer is paramount to accelerating innovation and bringing life-saving therapies to market faster.